AMR Stakeholder Profile
Focus area/active in: Human Health
Company/Organisation type: Association | Cluster | Network
The aim of the IMI Antimicrobial Resistance (AMR) Accelerator is to progress the development of new medicines to treat or even prevent resistant bacterial infections in Europe and worldwide. The AMR Accelerator comprises 9 projects with focus on Tuberculosis, Gram-negative bacteria, and capability building. The scope of the AMR Accelerator is broad; under one structure, it addresses many of the scientific challenges of AMR, with the shared goal is to progress the development of new medicines to treat or prevent resistant bacterial infections.
AMR Accelerator Newsletter
Get in touch!
Prof. Anders Karlén
COMBINE Project Coordinator
Please fill out the form below to get in touch with us.